All News Kinnevik AB London S.E.

Equities

0RGZ

SE0015810239

Market Closed - London S.E. Other stock markets 11:25:00 2024-05-02 am EDT			5-day change	1st Jan Change
440 ^SEK	0.00%		+280.62%	+312.01%

Apr. 18	KINNEVIK INVESTMENT : Kinnevik delivers lacklustre results but rewards shareholders
Apr. 18	Tele2: net profit of SEK 0.8 billion	CF

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KINNEVIK: NOTICE OF THE 2024 ANNUAL GENERAL MEETING	03:00am	AQ
The Nomination Committee's proposed Board composition	02:00am	AQ
Decreased number of shares and votes in Kinnevik	Apr. 30	AQ
Kinnevik completes the second step of the divestment of its shareholding in Tele2 and receives 9.4bn in gross sales proceeds	Apr. 25	AQ
Redemption of incentive shares in Kinnevik	Apr. 22	AQ
KINNEVIK INVESTMENT : Kinnevik delivers lacklustre results but rewards shareholders	Apr. 18
Tele2: net profit of SEK 0.8 billion	Apr. 18	CF
Transcript : Kinnevik AB, Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Kinnevik : Interim Report 1 January - 31 March 2024	Apr. 18	PU
Kinnevik’s Interim Report 1 January – 31 March 2024	Apr. 18	AQ
Kinnevik AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Kinnevik : Board of Directors concludes its capital structure review - intends to propose an extraordinary cash distribution of SEK 23 per share	Apr. 17	PU
Kinnevik’s Board of Directors concludes its capital structure review – intends to propose an extraordinary cash distribution of SEK 23 per share	Apr. 17	AQ
Kinnevik AB Proposes Extraordinary Cash Distribution	Apr. 17	CI
KINNEVIK INVESTMENT : Accounting for the sale of Tele2	Apr. 14
Kinnevik publishes Annual & Sustainability Report 2023	Apr. 04	AQ
Kinnevik : Conference call to present Kinnevik's first quarter results 2024	Apr. 03	PU
Tele2's Nomination Committee proposes a revised Board composition to the Annual General Meeting	Apr. 03	AQ
Conference call to present Kinnevik’s first quarter results 2024	Apr. 03	AQ
Digital Therapeutics, Inc. announced that it has received $58 million in funding from GreyMatter BrainTrust LLC, Eight Roads Ventures, Atomico Investment Holdings Limited, Octopus Ventures Ltd., Y Combinator Management, LLC, Kinnevik AB and other investors	Mar. 27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

KINNEVIK INVESTMENT : Kinnevik delivers lacklustre results but rewards shareholders

April 18, 2024 at 10:06 am EDT